First-of-its-Kind EndoStim System Discovered for the Treatment of Drug Refractory GERD

EndoStim discovers first-of-its-kind EndoStim System for the treatment of drug refractory gastroesophageal reflux disease (GERD).EndoStim System is represented as a new treatment potential in development for drug refractory GERD.

The EndoStim Systemis composed of animplantable neurostimulation device and lead placed via a quick, minimally-invasive laparoscopic procedure. This system automatically delivers long-term reflux controland mild electrical signals to the patient’s weak or dysfunctional lower esophageal sphincter (LES) muscle (the underlying cause of GERD).

The EndoStim system,makes use of external handheld controller,without the need of physician to automatically stimulate the LES to allow it to function normally without any sensation to the patient.

GERD (gastroesophageal reflux disease) is a digestive disorderaffecting the ring of muscle between the esophagus and the stomach, the lower esophageal sphincter (LES). This condition generally occurs whenstomach contents leak backward from the stomach into the esophagus.

Nearly 1 in 3 (7.5 million) GERD patients taking high dose proton pump inhibitor (PPI) medications for GERD, continue to suffer from bothersome GERD symptoms.